Gene therapy to control hypertension: current studies and future perspectives

Area of Science:

• Cardiovascular Medicine
• Molecular Medicine
• Genetics

Background:

• Hypertension is a complex condition with severe complications like heart failure and kidney dysfunction.
• Traditional therapies offer symptomatic relief but lack long-term efficacy and face compliance issues.
• Advances in gene transfer necessitate exploring novel therapeutic strategies for sustained hypertension management.

Purpose of the Study:

• To review gene therapy strategies for hypertension, comparing sense and antisense approaches.
• To evaluate viral and nonviral vectors for systemic gene delivery in hypertension research.
• To summarize research on retrovirus-mediated delivery of angiotensin type I receptor-antisense.

Main Methods:

• Comparative analysis of sense and antisense gene therapy strategies.
• Assessment of viral (e.g., retrovirus) and nonviral delivery vectors.
• Review of experimental data on gene transfer for hypertension.

Main Results:

• Gene therapy holds potential for lasting antihypertensive effects by modulating hypertension-associated genes.
• Retrovirus-mediated delivery of angiotensin type I receptor-antisense shows promise in preventing hypertension.
• Both viral and nonviral vectors have distinct advantages and disadvantages for gene delivery.

Conclusions:

• Gene therapy presents a viable alternative for long-term hypertension management.
• Antisense strategies, particularly with effective vector delivery, could revolutionize hypertension treatment.
• Further research is needed to optimize gene therapy for clinical application in hypertension.